6 completed, 2 unknown, 1 recruiting, 1 terminated. 6 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow AV Fistula: new trials by email Literature Review of AV Fistula trials Research Report on AV Fistula
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery Tarvos Microguidewire - Intracranial Aneurysm, AVM - Cerebral Arteriovenous Malformation | Completed | Keuro MedTech | 121 | 2026-01-29 | 2026-04-02 | |
| av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia doppler ultrasound - AV Fistula | Unknown | Assiut University | 120 | 2022-12-01 | 2022-10-06 | |
| Alucent Vessel Restoration System for AVF Alucent Vessel Restoration System for AVF - AV Fistula | Not applicable | Unknown | Alucent Biomedical | 30 | 2022-07-15 | 2024-03-13 |
| Ellipsys Vascular Access System Post Market Surveillance (PS) Study Ellipsys Vascular Access System - Renal Disease, End Stage, Kidney Disease, End-Stage | Not applicable | Completed | Medtronic Endovascular | 142 | 2021-04-13 | 2026-06-01 |
| The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation WavelinQ™ EndoAVF System - End Stage Kidney Disease, Chronic Kidney Diseases | Not applicable | Terminated | C. R. Bard | 21 | 2020-12-23 | 2025-01-16 |
| SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications SELUTION SLR™ DEB, Control Arm - AV Fistula | Not applicable | Completed | M.A. Med Alliance S.A. | 84 | 2020-04-10 | 2025-08-29 |
| Tissue Markers Predictive of Early Stenosis in the Arterovenous Fistula for Hemodialysis Identification any tissue markers predictive or favoring early stenosis in AVF for haemodialysis. - AV Fistula | Not applicable | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 150 | 2020-03-18 | 2025-02-07 |
| Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access Vorapaxar sulfate, Placebo - AV Fistula | Phase 2 | Completed | Ken Mahaffey | 17 | 2015-08-26 | 2019-01-14 |
| Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Ellipsys Vascular Access Catheter - End Stage Renal Disease, AV Fistula | Not applicable | Completed | Medtronic Endovascular | 103 | 2015-02-10 | 2021-11-09 |
| Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Venous Window Needle Guide - End Stage Renal Disease, AV Fistula | Phase 2 / Phase 3 | Completed | Vital Access Corp. | 54 | 2011-12-01 | 2016-06-03 |
Arteriovenous Fistula (10) · Kidney Failure, Chronic (4) · Renal Insufficiency (2) · Fistula (1) · Hyperphosphatemia (1) · Intracranial Aneurysm (1) · Intracranial Arteriovenous Malformations (1) · Ischemic Stroke (1) · Renal Insufficiency, Chronic (1)
Arteriovenous Malformations (10) · Cardiovascular Abnormalities (10) · Cardiovascular Diseases (10) · Congenital Abnormalities (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Pathological Conditions, Anatomical (10) · Pathological Conditions, Signs and Symptoms (10) · Vascular Diseases (10) · Vascular Fistula (10) · Vascular Malformations (10) · Fistula (9) · Chronic Disease (4) · Disease Attributes (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4)
Dialysis (1) · Ultrasonography, Doppler (1) · vorapaxar (1)
Medtronic Endovascular (2) · Alucent Biomedical (1) · Assiut University (1) · C. R. Bard (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Ken Mahaffey (1) · Keuro MedTech (1) · M.A. Med Alliance S.A. (1) · Vital Access Corp. (1)
United States (4) · Greece (2) · Australia (1) · Belgium (1) · China (1) · Egypt (1) · Italy (1) · Poland (1) · Singapore (1) · Switzerland (1)
Charmaine Lok, MD, MSc (1) · Haimanot Wasse, MD (1) · Jeffrey Hull, MD (1) · Kenneth W Mahaffey, MD (1) · Mark Crawford, BA (1) · Matthew W Mell, MD, MS (1) · Mauro Gargiulo, MD (1) · Nicholas Inston, PhD (1) · Panagiotis Kitrou, MD, MSc, PhD (1)